Comments for OXGN - Stockpickr! Your Source for Stock Ideas

Comments for OXGN

Added By	Comments	Type	Date Added
JBOND	RESEARCH BREAKTHROUGH	Love	July 02, 2009
barrons2	Market Outperform/Speculative Risk - Price 1.96 on Feb. 28 by Rodman & Renshaw Target: 4. With a technology platform designed to address both oncology and ophthalmology indications, promising clinical and preclinical news flow expected in six to 18 months, potential for at least one partnership in 2008, and an EV of $27.5 million, we believe OXiGENE is...significantly undervalued. Market-cap: $56 million.	Love	March 01, 2008
dvance	drugs moving into high gear	Love	July 04, 2007
dvance	redy to move ,traded way over average	Love	April 23, 2007
bubbastarr	Good drug pipeline.	Love	March 06, 2007
thongchi	fda approval for potential drug pipelines.	Love	February 18, 2007